Guidelines and education

EMAS Position Statements


EMAS is proud to publish position statements written by international experts on management of health conditions affecting midlife health and beyond. Recommendations are evidence based and suitable for integration into local guidelines worldwide

EMAS Menopause Essentials


Women’s health is increasingly recognized as a global health priority. Managing perimenopausal and postmenopausal health is a key issue worldwide. Therefore EMAS is making available to all short fact sheets to help women, healthcare and non healthcare professionals understand menopausal health.

EMAS Care Online 2020

EMAS Care Online consists on summaries and advice for clinicians and researchers involved in midlife health.

EMAS Menopause in the Workplace


In 2020 there were 657 million women aged 45- 59, many contributing to the workforce throughout their menopausal years. Although the average age of the natural menopause is 51, it can occur earlier, either naturally or induced by surgery, radiotherapy and chemotherapy. While the menopause may cause no significant problems for some women, for others it is known to present considerable difficulties in both their personal and working lives. Workplace health and wellbeing frameworks and policies should therefore incorporate menopausal health as part of the wider context of gender and age equality and reproductive and post-reproductive health.

Does your organization have a Menopause policy or guidance?
September 7 is World Menopause & Work Day!
EMAS 2021 Global Recommendations on Menopause in the Workplace
Menopause & Work Charter

For a menopause-friendly workplace

Menopause at a Glance: Infographics

To illustrate the 2021 EMAS Global Recommendations on menopause in the workplace

Press Releases & Media Coverage
Menopause Essentials 2021

A general leaflet on menopause, its symptoms and its effects on the workplace and in private life

Self-Assessment Tool

For employers and managers

Population Statistics

For international and European statistics

Written evidence from Professor Kathleen Riach

On behalf of the International Menopause/Work Consortium [MEW0069] to the UK Parliament

The Webinar Series

Watch the video recordings

Research on Menopause in the Workplace

Research updates from 2015 to present

Recommendations by non-EMAS Organisations

Guidelines from healthcare societies, personnel, and support organisations

Non EMAS educational materials

Writing and publishing research papers, reviews and case reports 2020

Here are links to educational materials and papers for preparing submissions


Consent and ethical approval

  • Health Research Authority

  • Roguljić M, Ščepanović R, Rees M. Writing case reports, consent for publication and General Data Protection Regulation (GDPR). Case Rep Womens Health.

    2020, e00204.

Elsevier resources

The Global AWARE Group Educational Materials

The global AWARE (Appropriate care for Women with AndRogen Excess) group is a panel of independent physicians with an expert interest in androgen excess. Their mission is to address the unmet need in androgen excess to ensure that women receive appropriate care. Since its formation in 2015, the AWARE group and its ongoing work is supported by Bayer. The group have created a number of useful resources that are available to download below. These resources aim to support healthcare professionals in the recognition, diagnosis and appropriate treatment of androgen excess. You may want to use these materials to support discussions with colleagues, for example, in a workshop setting.

The AWARE group is a panel of independent physicians with an expert interest in androgen excess in women.

Formation of the AWARE group and its ongoing work is supported and funded by Bayer AG.